Peer-influenced content. Sources you trust. No registration required. This is HCN.
Ophthalmology Management
A boutique cataract surgeon describes a multi-technology, team-aligned workflow associated with a reported 92% premium IOL conversion rate.
Ophthalmology May 4th 2026
Ophthalmology Advisor
Femtosecond laser-assisted cataract surgery showed no safety advantage over conventional phacoemulsification across 17 randomized trials and 4,466 eyes.
Conexiant
Early trials suggest red‑light therapy may slow pediatric myopia progression, but unanswered questions around long‑term retinal safety and clinical positioning remain.
Ophthalmology April 20th 2026
Optometric Management
A nationwide recall of more than 3 million OTC eye drops due to sterility concerns highlights the importance of routine patient counseling around non‑prescription ocular products.
Retina Today
Vigabatrin can cause irreversible peripheral retinal toxicity that is often asymptomatic, underscoring the need for consistent ophthalmic monitoring in treated patients.
FDA approval of 20‑week dosing for Eylea HD offers eligible wAMD and DME patients the potential for fewer injections while maintaining long‑term visual outcomes.